Companies

CRISPR Therapeutics AG (CRSP) SEC filings

CIK 0001674416 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in V8 · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2021
Revenue (USD)3.5 M1.2 M
Net income (USD)-348.9 M66.9 M
Diluted EPS (USD/shares)-6.47-8.36

Latest filings

FiledFormDescriptionPeriod
2026-10-21442026-10-19
2026-10-21332026-10-19
2026-10-20442026-10-16
2026-10-198-K8-K items 5.02,9.012026-10-19
2026-10-16442026-10-14
2026-10-15442026-10-13
2026-10-15442026-10-13
2026-10-14144144
2026-10-08442026-10-06
2026-10-06144144
2026-09-24442026-09-22
2026-09-22144144
2026-09-21442026-09-17
2026-09-21442025-08-06
2026-09-17144144
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-11442026-08-07
2026-08-0310-Q10-Q2026-06-30
2026-08-038-K8-K items 2.02,9.012026-08-03
2026-07-27SCHEDULE 13G/ASCHEDULE 13G/A
2026-06-09442026-06-05
2026-06-09442026-06-05
2026-06-09442026-06-05
2026-06-09442026-06-05
2026-06-09442026-06-05

Forms on file (last 1,000): 4 450, 8-K 135, 3 36, 10-Q 30, SC 13G/A 24, 144 20, SC 13D/A 19, 424B5 17. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=CRSP (0.002 USD), /gw/filings/filings?ticker=CRSP&form=8-K, /gw/filings/facts?ticker=CRSP&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange